Evidence map›Paper›PMID 32710973›Full record

ReviewThe Journal of allergy and clinical immunology2020

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

Zita-Rose Manjaly Thomas, Anne Leuppi-Taegtmeyer, Dagmar Jamiolkowski, Esther Steveling-Klein, Felicitas Bellutti-Enders, Kathrin Scherer Hofmeier, Karin Hartmann

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of allergy and clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zita-Rose Manjaly ThomasDivision of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Anne Leuppi-TaegtmeyerRegional Pharmacovigilance Centre, Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland; Department of Pharmaceutical Sciences, University Hospital Basel, Basel, Switzerland.
Dagmar JamiolkowskiDepartment of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland.
Esther Steveling-KleinDivision of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Felicitas Bellutti-EndersDepartment of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Allergy Unit, University Children's Hospital Basel, Basel, Switzerland.
Kathrin Scherer HofmeierDivision of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Karin HartmannDivision of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: karin.hartmann@usb.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCoronavirus InfectionsCytokine Release SyndromeDrug HypersensitivityImmunologic FactorsPneumonia, ViralAdenosine MonophosphateAdrenal Cortex HormonesAlanineAmidesAntibodies, Monoclonal, HumanizedBetacoronavirusCOVID-19HumansImmunity, InnateIndolesAdenosine MonophosphateAdrenal Cortex HormonesAlanineAmidesAntibodies, Monoclonal, HumanizedAntiviral AgentsfavipiravirImmunologic FactorsIndolesInfliximabInterleukin 1 Receptor Antagonist ProteinNitrilesPyrazinesPyrazolesPyrimidinesremdesivirruxolitinibsarilumabSulfidestocilizumabumifenovirAcute respiratory syndromeadverse drug reactionscoronavirusCOVID-19drug allergydrug hypersensitivityremdesivirSARS-CoV-2

Identifiers

PMID32710973
PMCPMC7833501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.